29, 2025 (GLOBE NEWSWIRE) -- This industry analysis defines "best" based on public visibility, consumer interest signals, and availability of verifiable company disclosures, not medical efficacy
With respect to the primary endpoint of A1C reduction from baseline, dulaglutide 4.5 mg was superior to the 1.5 mg dose at Week 36 under the treatment regimen estimand (mean change from baseline [mean baseline 8.6%]: dulaglutide 1.5 mg -1.54%, dulaglutide 4.5 mg -1.77%
PMID 24499291
The manufacturer prescribing information for Janumet XR provides label-backed details for clinicians and patients
Did you know that your Towel Steamers vent moisture into the air
Developing a system to remember when to take it each week may also help reduce the risk of errors in dosing. While most patients who had GLP-1 RA overdose reported no symptoms, gastrointestinal symptoms such as nausea, vomiting, generalized weakness and abdominal pain are some of the most common when symptoms occur